到 2028 年亚太地区数字病理学市场预测 - 按产品（扫描仪、软件、存储和通信系统）、应用程序（远程病理学、疾病诊断、药物发现以及培训和教育）和最终用户（教育、临床、制药和生物技术公司）

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028

No. of Pages: 167    |    Report Code: TIPRE00024451    |    Category: Life Sciences

Explore in Your Language
English Arabic French German Italian Japanese Korean Spanish
Asia Pacific Digital Pathology Market
Free Sample Buy Now

亚太地区数字病理市场预计将从2022年的2.063亿美元增长到2028年的4.2603亿美元。预计2022年至2028年复合年增长率为12.8% . 

在药物开发中使用数字病理学将为 2022 年和 2028 年亚太地区数字病理学市场提供利润丰厚的机会

药物开发是一个耗时且劳动密集型的过程。科学家和病理学家检查大量样本，以评估药物如何影响特定组织或动物。在此过程中可以采用数字病理学和人工智能（AI）来提高整体效率。毒理学研究会生成大量幻灯片，仅在工作流程中添加数字成像和人工智能就可能会减少工作时间。这使得病理学家能够专门关注具有变化的幻灯片，例如病变，这对于理解药物机制至关重要。此外，数字图像处理能够从图像中推断和记忆大量数据，这超出了研究人员的能力。此外，计算机可以存储其编程的所有内容，这有助于创建信息丰富的数据库。此外，收集、分析和共享数据的过程变得毫不费力。数字化信息可以与世界上任何地方的任何人共享，病理学家也可以从远程位置访问数据。所有这些方面都导致了结构化、有效、高质量和有针对性的药物研究。此外，数字病理学为病理学家提供了与任何人在重大专业项目上进行合作的灵活性，进一步改善了亚太地区的药物发现。

制药制造商正在利用数字病理学的优势在药物开发中。例如，2022 年 4 月，葛兰素史克 (GSK) 聘请 PathAI 将数字病理学 AI 引入癌症和 NASH 药物开发。 GSK 和 PathAI 签署了一项多年期协议，联手改善该制药商在 NASH 及其肿瘤产品组合中的分子发现和临床试验工作。

市场概览 

亚太地区数字病理市场分为中国、日本、印度、澳大利亚、韩国和亚太地区其他地区。亚太地区市场的增长归因于中国政府不断采取的举措和支持、癌症病例的增加、日本行业参与者的日益关注以及印度医疗保健基础设施的发展等主要因素。数字病理扫描仪在癌症的早期诊断及其治疗中发挥着至关重要的作用。借助数字病理扫描仪获得癌组织的图像并使用软件进行分析。数字病理学系统的进步使得图像可视化和这些组织的分析成为可能，从而有助于癌症治疗。据 Globocan 报告，2020 年，日本新增癌症病例约 1,028,658 例，癌症死亡人数为 420,124 人。为了减少癌症病例的数量，日本注重改善癌症的早期诊断。此外，国内还安排了一些国家级会议，提供各种癌症诊断的知识和讲座。例如，亚太肿瘤学峰会Cancer于2017年5月举行。本次会议的目的是癌症活检以及影像学测试和诊断。由于日本行业参与者的这些发展和关注，数字病理市场可能在预测期内增长。 

亚太数字病理市场收入和预测到 2028 年（百万美元）

 

亚太数字病理市场细分

亚太数字病理市场细分为产品、类型、应用和最终用户。

根据产品，市场分为扫描仪、软件、存储和通信系统。扫描仪细分市场在 2022 年占据最大的市场份额。根据类型，市场分为人类病理学和兽医病理学。到 2022 年，人类病理学领域将占据更大的市场份额。根据应用，市场分为药物发现、疾病诊断、远程会诊以及培训和培训。教育。到 2022 年，药物发现领域将占据更大的市场份额。根据最终用户，市场分为制药和生物技术公司、医院和学术机构。 2022 年，制药和生物技术公司细分市场占据最大的市场份额。根据国家/地区，该市场分为日本、中国、印度、澳大利亚、韩国和亚太其他地区。 2022 年，日本在市场份额中占据主导地位。尼康公司；珀金埃尔默公司；籼稻实验室； 3DHISTECH 有限公司；滨松光子学公司； F.霍夫曼-拉罗氏有限公司； Visiopharm A/S； Glencoe Software, Inc. 和丹纳赫公司。是该地区数字病理学领域的领先公司。



Asia Pacific Digital Pathology Strategic Insights

Strategic insights for Asia Pacific Digital Pathology involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-digital-pathology-market-strategic-framework.webp
Get more information on this report

Asia Pacific Digital Pathology Report Scope

Report Attribute Details
Market size in 2022 US$ 206.30 Million
Market Size by 2028 US$ 426.03 Million
Global CAGR (2022 - 2028) 12.8%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 产品
  • 扫描仪
  • 软件
  • 存储
  • 通信系统
By 应用
  • 远程病理学
  • 疾病诊断
  • 药物研发
  • 培训与教育
By 最终用户
  • 教育
  • 临床
  • 制药和生物技术公司
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Koninklijke Philips N.V.
  • Nikon Corporation
  • Perkin Elmer, Inc.
  • Indica Labs
  • 3DHISTECH Ltd.
  • Hamamatsu Photonics K.K.
  • F. Hoffmann-La Roche Ltd
  • Visiopharm A/S
  • Glencoe Software, Inc.
  • Danaher Corporation
    		•
    Get more information on this report

    Asia Pacific Digital Pathology Regional Insights

    The regional scope of Asia Pacific Digital Pathology refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-digital-pathology-market-geography.webp
    Get more information on this report
    Identical Market Reports with other Region/Countries

    The List of Companies - Asia Pacific Digital Pathology Market

    1. Koninklijke Philips N.V.                                                                 
    2. Nikon Corporation                                                                          
    3. Perkin Elmer, Inc.                                                            
    4. Indica Labs                                                                                         
    5. 3DHISTECH Ltd.                                                                                
    6. Hamamatsu Photonics K.K.                                                         
    7. F. Hoffmann-La Roche Ltd                                                           
    8. Visiopharm A/S                                                                                
    9. Glencoe Software, Inc.               
    10. Danaher Corporation
    Frequently Asked Questions
    How big is the Asia Pacific Digital Pathology Market?

    The Asia Pacific Digital Pathology Market is valued at US$ 206.30 Million in 2022, it is projected to reach US$ 426.03 Million by 2028.

    What is the CAGR for Asia Pacific Digital Pathology Market by (2022 - 2028)?

    As per our report Asia Pacific Digital Pathology Market, the market size is valued at US$ 206.30 Million in 2022, projecting it to reach US$ 426.03 Million by 2028. This translates to a CAGR of approximately 12.8% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Digital Pathology Market report typically cover these key segments-

  • 产品 (扫描仪, 软件, 存储, 通信系统)
  • 应用 (远程病理学, 疾病诊断, 药物研发, 培训与教育)
  • 最终用户 (教育, 临床, 制药和生物技术公司)

    • What is the historic period, base year, and forecast period taken for Asia Pacific Digital Pathology Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Digital Pathology Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
    • Who are the major players in Asia Pacific Digital Pathology Market?

    The Asia Pacific Digital Pathology Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Koninklijke Philips N.V.
  • Nikon Corporation
  • Perkin Elmer, Inc.
  • Indica Labs
  • 3DHISTECH Ltd.
  • Hamamatsu Photonics K.K.
  • F. Hoffmann-La Roche Ltd
  • Visiopharm A/S
  • Glencoe Software, Inc.
  • Danaher Corporation
    • Who should buy this report?

    The Asia Pacific Digital Pathology Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Digital Pathology Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Request Free Sample Buy Now
    asia-pacific-digital-pathology-market